Where does the Car T therapy owned by CHM sit if IMU acquires the ‘better’ therapy from Precision? This is a genuine query but why didn’t CHM acquire the Precision Car T and add to its portfolio and then do a deal with IMU rather than introduce them when in fact there are common directors? Doesn’t this leave CHM out of the future? Expect to be howled down but just asking for genuine views.
Ann: Chimeric to receive A$4.4 million introduction fee, page-19
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $28.14K | 7.037M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 243067 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 14771167 | 22 |
View Market Depth
| Last trade - 15.39pm 20/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |